Our mission is to introduce an innovative, high-quality intrauterine drug-delivery technology to improve and impact women’s health and quality of life
This Is What We Do
Finally, women’s health products that are designed and managed by women for women that fit women’s anatomy and needs.
OCON’s platform technology excels in simplicity, safety, cost-effectiveness, new and innovative technology.
in the media
OCON Therapeutics has reached its recruitment goal of its Phase IIb clinical study evaluating the revolutionary IUB® SEAD®, a non-invasive treatment for heavy menstrual bleeding affecting 1 in 3 women
OCON Therapeutics is honored to be part of Bolt PR’s (A Millwright Agency) important list of Femtech Brands and Innovations to watch in 2023
1 compared to literature of Traditional IUDs and ongoing vigilance reporting for IUB® BALLERINE®, OCON Medical Ltd.
2 ongoing Phase II Clinical Studies, OCON Medical Ltd.